Bloomington, IN, is the home of Indiana Hoosiers basketball – and the center of Catalent’s biologics drug substance manufacturing operations. And while the university’s forward Trayce Jackson-Davis might be leaving town early to declare for the NBA Draft, the CDMO has made it clear that it isn’t going anywhere.
On Thursday, Catalent announced a multi-year, $350 million investment at the Bloomington site to expand drug substance and product manufacturing. The additions will include new bioreactors, syringe filling lines and lyophilization capacity, as well as automated packaging upgrades and quality control labs.
"crowded" - Google News
April 22, 2022 at 01:04AM
https://ift.tt/pogNalK
Crowded rheumatoid arthritis category gets JAK reality check, while TNF stalwarts continue to dominate: study - Endpoints News
"crowded" - Google News
https://ift.tt/0OmAcgX
https://ift.tt/47PNJxc
Bagikan Berita Ini
0 Response to "Crowded rheumatoid arthritis category gets JAK reality check, while TNF stalwarts continue to dominate: study - Endpoints News"
Post a Comment